Superantigen

Indian Journal of Dermatology, Venereology and Leprology

Volumn 75, Issue 5, 2009, Pages 540-544

  Vaishnani, Jignesh ^a  

^a SMIMER   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ALEFACEPT; B LYMPHOCYTE RECEPTOR; BAICALIN; CELL MEMBRANE PROTEIN; CLINDAMYCIN; CORTICOSTEROID; CYCLOSPORIN; CYTOKINE RECEPTOR ANTAGONIST; EFALIZUMAB; EPITOPE; ETANERCEPT; GAMMA INTERFERON; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; INFLIXIMAB; INTERLEUKIN 2; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MITOGENIC AGENT; PENTOXIFYLLINE; STA 5236; STAPHYLOCOCCUS ENTEROTOXIN; STAPHYLOCOCCUS PROTEIN A; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR; THALIDOMIDE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VACCINE;

ABSCESS DRAINAGE; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBODY COMBINING SITE; ANTIGEN PRESENTING CELL; ARTHUS PHENOMENON; ATOPIC DERMATITIS; AUTOIMMUNITY; B LYMPHOCYTE ACTIVATION; BACTERIUM; BURKITT LYMPHOMA; CAPILLARY LEAK SYNDROME; CELL STIMULATION; CHRONIC ARTHRITIS; CLONAL ANERGY; CROHN DISEASE; CYTOKINE RELEASE; CYTOMEGALOVIRUS INFECTION; CYTOTOXICITY; EPSTEIN BARR VIRUS; FOOD POISONING; HLA SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMORAL IMMUNITY; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; INFECTIOUS MONONUCLEOSIS; INSULIN DEPENDENT DIABETES MELLITUS; MACROPHAGE; MUCOCUTANEOUS LYMPH NODE SYNDROME; MYCOPLASMA; MYCOPLASMA ARTHRITIDIS; PROTEIN INTERACTION; RABIES; RETROVIRUS INFECTION; REVIEW; RHEUMATIC FEVER; RHEUMATOID ARTHRITIS; SCARLET FEVER; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; T LYMPHOCYTE ACTIVATION; TOXIC SHOCK SYNDROME; TREATMENT INDICATION; VASCULITIS; VIRUS; YERSINIA PSEUDOTUBERCULOSIS;

ANIMALS; BACTERIAL PROTEINS; HUMANS; LYMPHOCYTE ACTIVATION; RECEPTORS, ANTIGEN, B-CELL; RECEPTORS, ANTIGEN, T-CELL; SUPERANTIGENS;

EID: 70349436116     PISSN: 03786323     EISSN: None     Source Type: Journal    
DOI: 10.4103/0378-6323.55423     Document Type: Review

References (18)

1. Kappler J, Kotzin B, Herron L, Gelfand EW, Bigler RD, Boylston A, Carrel S, Posnett DN, Choi Y, Marrack P. V beta-specific stimulation of human T cells by staphylococcal toxins. Science 1989;244:811-813
2. Parish WE, Breathnach SM. Clinical Immunology and Allergy. In: Champion RH, Burton JL, Burns DA, Breathnach SM, editors. Rook Textbook of dermatology. 6th edition. Oxford: Blackwell Science 1998. p. 277-336
3. Janeway CA, Travers P, Walport M, Shlomchik MJ, editors. Antigen recognition by B cell and T cell receptors. In: Immunobiology, The immune system in health and disease; 5th edition. London: Garland Publishing: 2001. p. 93-122.
4. Choi Y, Lafferty JA, Clements JR, Todd JK, Gelfand EW, Kappler J, Marrack P, Kotzin BL. Selective expansion of T cells expressing V beta 2 in toxic shock syndrome. J Exp Med 1990;172:981-984
5. Llewelyn M, Cohen J. Superantigen: Microbial agents that corrupt immunity.The lancet infectious disease 2002;2:156-162
6. Kozlowski LM, Li W, Goldschmidt M, Levinson AI. In vivo inflammatory response to a prototypic B cell superantigen: Elicitation of an arthus reaction by staphylococcal protein A. J Immunol 1998;160:5246-5252
7. Bette M, Schafer MK, Rooijen VN, Weihe E and Fleischer B. Distribution and kinetics of superantigen-induced cytokine gene expression in mouse spleen. J Exp Med 1993;178:1531-1539
8. Renno T, Hahne M, Tschopp J, MacDonald HR. Peripheral T Cells Undergoing Superantigen-induced Apoptosis In vivo Express B220 and Upregulate Fas and Fas ligand. J Exp Med 1996;183:431-437
9. Kawabe Y, Ochi A. Selective anergy of V β 8+, CD4Tcells in staphylococcus enterotoxin B-primed mice. J Exp Med 1990;172:1065-1070
10. Torres BA, Perrin GQ, Mujtaba MG, Subramaniam PS, PS, Anderson AK, Johnson HM. Superantigen enhancement of specific immunity:antibody production and signaling pathway. J Immunol 2002;169:2907-2914
11. Holzer U, Orlikowsky T, Zehrer C, Bethge W, Dohlsten M, Kalland T; et al. T-cell stimulation and cytokines release induced by staphylococcal enterotoxin A (SEA) and SEAD227A mutant. Immunol 1997;90:74-80.
12. Tchilian EZ, Anderson G, Moore NC, Owen JJ, Jenkinson EJ. Involvement of LFA/ICAM-2 adhesive interaction and PKC in activation induced cell death following SEB rechallange. J Immunol 1996;87:566-572
13. Koning F, Rust C. Staphylococcal enterotoxin mediated human T-T cell interaction. J Immunol 1992;149:317-322
14. Friedman SM, Posnett DN, Tumang JR, Cole BC, Crow MK. A potential role for microbial superantigens in the pathogenesis of systemic autoimmune disease. Arthritis Rheum 1991;34:468-480
15. Crow MK. Connective tissue disorders-systemic lupus erythematosus, cellular immunology. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH editors. Rheumatology 3rd edition. Philadelphia: MOSBY (Elsevier Science); 2003 p.1347-1358.
16. Hauk PJ, Hamid QA, Chrousos GP, Leung DY. Induction of corticosteroid insensitivity in human PBMCs by microbial superantigens. J Allergy Clin Immunol 2000;105:782-787
17. Anderson AL, Sporici R, Lambris J, Larosa D, Levision AI. Pathogenesis of B cell Superantigen induced immune complex mediated inflammation. Infection and Immunity 2006; 74:1196-1203.
18. Pousnett DN, Yarilina AA. Sleeping with enemy-Endogenous superantigen in humans. Immunity 2001;15:503-506